---
title: "EPIC2: integrate single-cell chromatin accessibility with GWAS to pinpoint trait-relevant cell typ"
id: "biorxiv-3-epic2-integrating-single-cell-chromatin-accessibility-with-human-genetics-to"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-3-epic2-integrating-single-cell-chromatin-accessibility-with-human-genetics-to"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1?rss=1"
published_at: "2026-11-22T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# EPIC2: integrate single-cell chromatin accessibility with GWAS to pinpoint trait-relevant cell typ
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-3-epic2-integrating-single-cell-chromatin-accessibility-with-human-genetics-to
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1?rss=1)
- **Published At:** 2026-11-22T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- EPIC2 is a computational and statistical framework designed to prioritize **trait-relevant cell types** by combining human genetics with single-cell epigenomic data. - The method integrates genome-wide association study (**GWAS**) summary statistics with single-cell chromatin accessibility profiles to link genetic association strength to cell-type-specific regulatory signals. - Investigators reported that EPIC2 performs association testing at two resolutions: individual SNPs and regulatory peaks derived from chromatin accessibility data. - The framework explicitly accounts for **linkage disequilibrium (LD)** when performing association tests, an analytic control intended to reduce confounding from correlated variants. - Resulting P-values from SNP-level and peak-level tests are combined using the **Cauchy combination test**, according to the authors’ description. - The authors implemented the core workflow in R and made source code, vignettes, and reproducible test data publicly available on GitHub for user access. - Supplementary material accompanies the preprint; the paper is currently posted on bioRxiv and has not been peer reviewed. - The preprint declared no competing interests and listed NIH R35 GM138342 among funders; specific performance metrics, benchmarking details, and parameter settings were not reported in the abstract and require consultation of the full text or supplementary files. - The authors provided a project website and vignette for usage guidance; readers should consult those resources and the repository for implementation and reproducibility details not summarized in the abstract.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=SxO0OjUCJ2MmMxlBHPTnKvZWvHFfql1RRmbK5Khimps-1795378118.8280573-1.2.1.1-CGLdN.QyTVN4kFsItp35FYXNkUYNl0cGI7FT4GDEXVhwiKV8dYmlNGGwsTLrb2w.) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # EPIC2: integrating single-cell chromatin accessibility with human genetics to identify trait-relevant cell types [ View ORCID Profile](http://orcid.org/0009-0005-0502-4911)Lingxuan Zhu, [ View ORCID Profile](http://orcid.org/0000-0001-6905-6377)Yuchao Jiang doi: https://doi.org/10.64898/2026.11.12.766196 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Lingxuan Zhu Texas A&M University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lingxuan%2BZhu%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Zhu%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALingxuan%2BZhu%2B) * [ORCID record for Lingxuan Zhu](http://orcid.org/0009-0005-0502-4911 "Open in new tab") Yuchao Jiang Texas A&M University * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yuchao%2BJiang%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Jiang%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYuchao%2BJiang%2B) * [ORCID record for Yuchao Jiang](http://orcid.org/0000-0001-6905-6377 "Open in new tab") * For correspondence: yuchaojiang@tamu.edu * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5986191/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5986191/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5986191/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5986191/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5986191/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5986191/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Summary: EPIC2 is a computational and statistical framework for prioritizing trait-relevant cellular contexts by integrating genome-wide association study (GWAS) summary statistics with single-cell chromatin accessibility data. It accounts for linkage disequilibrium when testing for association between GWAS association strength and cell-type-specific chromatin accessibility at both SNP and regulatory-peak resolutions. The resulting P-values are combined using the Cauchy combination test. Availability and Implementation: The core workflow is implemented in R, with source code, vignettes, and reproducible test data freely available at https://github.com/LingxuanZ/EPIC2. Supplementary Information: Supplementary material accompanies this preprint. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * * ## Funder Information Declared National Institutes of Health, R35 GM138342 Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.10.765744v1 "High-Resolution Spatial Transcriptomics Reveals Millimeter-Scale Malignant Territories and Immune Exclusion patterns in Human Salivary Gland Adenoid Cystic Carcinoma") Posted November 22, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/22/2026.11.12.766196.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.12.766196v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/11/22/2026.11.12.766196.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) EPIC2: integrating single-cell chromatin accessibility with human genetics to identify trait-relevant cell types Lingxuan Zhu, Yuchao Jiang bioRxiv 2026.11.12.766196; doi: https://doi.org/10.64898/2026.11.12.766196 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.12.766196v1%26text%3DEPIC2%253A%2520integrating%2520single-cell%2520chromatin%2520accessibility%2520with%2520human%2520genetics%2520to%2520identify%2520trait-relevant%2520cell%2520types "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.12.766196v1%26t%3DEPIC2%253A%2520integrating%2520single-cell%2520chromatin%2520accessibility%2520with%2520human%2520genetics%2520to%2520identify%2520trait-relevant%2520cell%2520types "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.12.766196v1%26title%3DEPIC2%253A%2520integrating%2520single-cell%2520chromatin%2520accessibility%2520with%2520human%2520genetics%2520to%2520identify%2520trait-relevant%2520cell%2520types%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.12.766196v1%26title%3DEPIC2%253A%2520integrating%2520single-cell%2520chromatin%2520accessibility%2520with%2520human%2520genetics%2520to%2520identify%2520trait-relevant%2520cell%2520types "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.12.766196) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.11.12.766196v1&count=horizontal&via=&text=EPIC2%3A%20integrating%20single-cell%20chromatin%20accessibility%20with%20human%20genetics%20to%20identify%20trait-relevant%20cell%20types&counturl=www.biorxiv.org/content/10.64898/2026.11.12.766196v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46187) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20389) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27670) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14305) * [Ecology](https://www.biorxiv.org/collection/ecology) (21661) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (26070) * [Genetics](https://www.biorxiv.org/collection/genetics) (16511) * [Genomics](https://www.biorxiv.org/collection/genomics) (24132) * [Immunology](https://www.biorxiv.org/collection/immunology) (19299) * [Microbiology](https://www.biorxiv.org/collection/microbiology) (43780) * [Molecular Biology](https://www.biorxiv.org/collection/molecular-biology) (18619) * [Neuroscience](https://www.biorxiv.org/collection/neuroscience) (96446) * [Paleontology](https://www.biorxiv.org/collection/paleontology) (719) * [Pathology](https://www.biorxiv.org/collection/pathology) (3082) * [Pharmacology and Toxicology](https://www.biorxiv.org/collection/pharmacology-and-toxicology) (5289) * [Physiology](https://www.biorxiv.org/collection/physiology) (8390) * [Plant Biology](https://www.biorxiv.org/collection/plant-biology) (16489) * [Scientific Communication and Education](https://www.biorxiv.org/collection/scientific-communication-and-education) (2128) * [Synthetic Biology](https://www.biorxiv.org/collection/synthetic-biology) (4705) * [Systems Biology](https://www.biorxiv.org/collection/systems-biology) (10509) * [Zoology](https://www.biorxiv.org/collection/zoology) (2448) Reviews and Context x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments bioRxiv aims to provide a venue for anyone to comment on a bioRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by bioRxiv. bioRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the bioRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/20
## Related Clinical Research

- [MicroBioAgent: autonomous AI for end-to-end microbiome analysis](https://medichelpline.com/clinical-feed/biorxiv-3-microbioagent-an-ai-agent-for-automated-microbiome-analysis.md)
- [Dual LNP‑mRNA delivery restores hepatic function in mouse model of trifunctional protein deficiency](https://medichelpline.com/clinical-feed/biorxiv-4-dual-mrna-delivery-corrects-physical-and-biochemical-deficits-in-a-mouse-model.md)
- [Motherly Plus trial: Smartphone‑assisted single‑session psychotherapy for postpartum depression](https://medichelpline.com/clinical-feed/medrxiv-3-motherly-plus-study-protocol-of-a-randomized-controlled-trial-evaluating-a.md)
- [REMI: Free tool enabling truncated proximity searches in PubMed](https://medichelpline.com/clinical-feed/medrxiv-23-remi-a-free-tool-for-truncated-proximity-searching-in-pubmed.md)
- [Creatine for Healthy Aging: Examining a Decade of Use](https://medichelpline.com/clinical-feed/medical-news-today-0-age-appropriate-i-ve-taken-creatine-for-10-years-does-it-help-healthy-aging.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.